QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
ISPOR is coming up!
In just a few short weeks, the Quantify Research team will be on site at ISPORannual in Montreal.
Our team, Emilie Toresson Grip, Puneet Kaushik, Abraham Choong, and Kirk Geale, PhD – together with athagoras Group colleagues from IGES Lifescience – is looking forward to meeting clients and partner […]
Why Pharmacovigilance Data Quality Matters
In pharmacovigilance, high-quality data isn’t just about meeting regulatory checkboxes, it’s a vital cornerstone in protecting patient safety.
When pharmacovigilance falls short, the repercussions can be severe, from misleading safety statistics to, in the worst cases, preventable harm or even death. That’s why data quality is front and center, and the Nordic region offers a compelling example of how robust data can make a real difference.
Although Nordic countries represent just […]
Policy meets data: The design & execution of managed entry agreements
Yesterday, Quantify Research was invited to a hearing to present on the topic of managed entry agreement construction and follow up with Sveriges Kommuner och Regioner (within the regional collaboration model for medicines, “Regionernas Samverkansmodell för Läkemedel”).
Managed entry agreements […]
Quantify will be presenting at the Swedish Heath Economics Association´s annual meeting!
Our session titled” Will TLV´s new framework strengthen access to orphan drugs?” lead by Konstantin Macheridis, will provide an important discussion that parallels Quantify Research‘s contribution to the EFPIA – European Federation of Pharmaceutical Industries and Associations‘ W.A.I.T. report in collaboration with Lif – de forskande läkemedelsföretagen.
We are […]